Endogenous Transforming Growth Factor-β Inhibits Toll-Like Receptor Mediated Activation of Human Uterine Natural Killer Cells
Article first published online: 31 OCT 2006
American Journal of Reproductive Immunology
Volume 56, Issue 5-6, pages 321–328, November/December 2006
How to Cite
Eriksson, M., Meadows, S. K., Wira, C. R. and Sentman, C. L. (2006), Endogenous Transforming Growth Factor-β Inhibits Toll-Like Receptor Mediated Activation of Human Uterine Natural Killer Cells. American Journal of Reproductive Immunology, 56: 321–328. doi: 10.1111/j.1600-0897.2006.00432.x
- Issue published online: 31 OCT 2006
- Article first published online: 31 OCT 2006
- Submitted June 22, 2006; accepted September 7, 2006.
- Cellular activation;
- reproductive immunology;
- toll-like receptor
Problem Toll-like receptors (TLRs) recognition is an important means for the innate immune system to rapidly respond to pathogen invasion. Our aim was to determine whether uterine natural killer (uNK) cell cytokine production induced by stimulation through TLRs could be regulated by endogenous transforming growth factor (TGF)-β in human endometrium.
Method of study Single cells were isolated from human endometrium, and interferon (IFN)-γ production by endometrium cells and uNK cells was determined after stimulation by TLR agonists. The role of TGF-β in regulating this response was tested by blocking TGF-β function using antibodies or a specific inhibitor, SB431542.
Results TGF-β blockade increased TLR agonist induced IFN-γ by uNK cells. The regulation of uNK cell cytokine production was observed when uNK cells were incubated with agonists for TLR2 (PGN) or TLR3 (polyI:C). Blockade of TGF-β or TGF-β receptor signaling had no effect on constitutive cytokine production in the absence of TLR agonists.
Conclusion The results indicate that endogenous TGF-β alters cytokine responses of uNK cells in human endometrium in response to TLR agonists. These data suggest that uNK cell responses to microbial pathogens in the endometrium are regulated by the amount of biologically active TGF-β present within the human endometrium.